82 related articles for article (PubMed ID: 9753194)
1. Muscle could be the therapeutic target in SMA treatment.
Guettier-Sigrist S; Coupin G; Braun S; Warter JM; Poindron P
J Neurosci Res; 1998 Sep; 53(6):663-9. PubMed ID: 9753194
[TBL] [Abstract][Full Text] [Related]
2. Cell types required to efficiently innervate human muscle cells in vitro.
Guettier-Sigrist S; Coupin G; Warter JM; Poindron P
Exp Cell Res; 2000 Aug; 259(1):204-12. PubMed ID: 10942592
[TBL] [Abstract][Full Text] [Related]
3. Possible pathogenic role of muscle cell dysfunction in motor neuron death in spinal muscular atrophy.
Guettier-Sigrist S; Hugel B; Coupin G; Freyssinet JM; Poindron P; Warter JM
Muscle Nerve; 2002 May; 25(5):700-708. PubMed ID: 11994964
[TBL] [Abstract][Full Text] [Related]
4. On the possible role of muscle in the pathogenesis of spinal muscular atrophy.
Guettier-Sigrist S; Coupin G; Braun S; Rogovitz D; Courdier I; Warter JM; Poindron P
Fundam Clin Pharmacol; 2001 Feb; 15(1):31-40. PubMed ID: 11468011
[TBL] [Abstract][Full Text] [Related]
5. Degeneration of cocultures of spinal muscular atrophy muscle cells and rat spinal cord explants is not due to secreted factors and cannot be prevented by neurotrophins.
Braun S; Croizat B; Lagrange MC; Poindron P; Warter JM
Muscle Nerve; 1997 Aug; 20(8):953-60. PubMed ID: 9236785
[TBL] [Abstract][Full Text] [Related]
6. Establishing a standardized therapeutic testing protocol for spinal muscular atrophy.
Tsai LK; Tsai MS; Lin TB; Hwu WL; Li H
Neurobiol Dis; 2006 Nov; 24(2):286-95. PubMed ID: 16952456
[TBL] [Abstract][Full Text] [Related]
7. The developmental pattern of myotubes in spinal muscular atrophy indicates prenatal delay of muscle maturation.
Martínez-Hernández R; Soler-Botija C; Also E; Alias L; Caselles L; Gich I; Bernal S; Tizzano EF
J Neuropathol Exp Neurol; 2009 May; 68(5):474-81. PubMed ID: 19525895
[TBL] [Abstract][Full Text] [Related]
8. Restoring Bcl-x(L) levels benefits a mouse model of spinal muscular atrophy.
Tsai LK; Tsai MS; Ting CH; Wang SH; Li H
Neurobiol Dis; 2008 Sep; 31(3):361-7. PubMed ID: 18590823
[TBL] [Abstract][Full Text] [Related]
9. Constitutive muscular abnormalities in culture in spinal muscular atrophy.
Braun S; Croizat B; Lagrange MC; Warter JM; Poindron P
Lancet; 1995 Mar; 345(8951):694-5. PubMed ID: 7741893
[TBL] [Abstract][Full Text] [Related]
10. Abolishing Bax-dependent apoptosis shows beneficial effects on spinal muscular atrophy model mice.
Tsai MS; Chiu YT; Wang SH; Hsieh-Li HM; Lian WC; Li H
Mol Ther; 2006 Jun; 13(6):1149-55. PubMed ID: 16564230
[TBL] [Abstract][Full Text] [Related]
11. A human spinal cord cell promotes motoneuron survival and maturation in vitro.
Rouleau C; Mersel M; de Weille J; Rakotoarivelo C; Fabre C; Privat A; Langley K; Petite D
J Neurosci Res; 2009 Jan; 87(1):50-60. PubMed ID: 18752296
[TBL] [Abstract][Full Text] [Related]
12. Ciliary neurotrophic factor-induced sprouting preserves motor function in a mouse model of mild spinal muscular atrophy.
Simon CM; Jablonka S; Ruiz R; Tabares L; Sendtner M
Hum Mol Genet; 2010 Mar; 19(6):973-86. PubMed ID: 20022887
[TBL] [Abstract][Full Text] [Related]
13. Early disruption of neurovascular units and microcirculatory dysfunction in the spinal cord in spinal muscular atrophy type I.
Nobutoki T; Ihara T
Med Hypotheses; 2015 Dec; 85(6):842-5. PubMed ID: 26433686
[TBL] [Abstract][Full Text] [Related]
14. CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy.
Passini MA; Bu J; Roskelley EM; Richards AM; Sardi SP; O'Riordan CR; Klinger KW; Shihabuddin LS; Cheng SH
J Clin Invest; 2010 Apr; 120(4):1253-64. PubMed ID: 20234094
[TBL] [Abstract][Full Text] [Related]
15. Defective neuromuscular junction organization and postnatal myogenesis in mice with severe spinal muscular atrophy.
Dachs E; Hereu M; Piedrafita L; Casanovas A; Calderó J; Esquerda JE
J Neuropathol Exp Neurol; 2011 Jun; 70(6):444-61. PubMed ID: 21572339
[TBL] [Abstract][Full Text] [Related]
16. IGF-1 delivery to CNS attenuates motor neuron cell death but does not improve motor function in type III SMA mice.
Tsai LK; Chen YC; Cheng WC; Ting CH; Dodge JC; Hwu WL; Cheng SH; Passini MA
Neurobiol Dis; 2012 Jan; 45(1):272-9. PubMed ID: 21884794
[TBL] [Abstract][Full Text] [Related]
17. Corticomotoneuronal integrity and adaptation in spinal muscular atrophy.
Farrar MA; Vucic S; Johnston HM; Kiernan MC
Arch Neurol; 2012 Apr; 69(4):467-73. PubMed ID: 22491191
[TBL] [Abstract][Full Text] [Related]
18. Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice.
Dominguez E; Marais T; Chatauret N; Benkhelifa-Ziyyat S; Duque S; Ravassard P; Carcenac R; Astord S; Pereira de Moura A; Voit T; Barkats M
Hum Mol Genet; 2011 Feb; 20(4):681-93. PubMed ID: 21118896
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Ighmbp2 in motor neurons and implications for the pathomechanism in a mouse model of human spinal muscular atrophy with respiratory distress type 1 (SMARD1).
Grohmann K; Rossoll W; Kobsar I; Holtmann B; Jablonka S; Wessig C; Stoltenburg-Didinger G; Fischer U; Hübner C; Martini R; Sendtner M
Hum Mol Genet; 2004 Sep; 13(18):2031-42. PubMed ID: 15269181
[TBL] [Abstract][Full Text] [Related]
20. Motor neuron pathology and behavioral alterations at late stages in a SMA mouse model.
Fulceri F; Bartalucci A; Paparelli S; Pasquali L; Biagioni F; Ferrucci M; Ruffoli R; Fornai F
Brain Res; 2012 Mar; 1442():66-75. PubMed ID: 22306031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
